Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial. [PDF]
Implementation of yellow fever vaccination is currently hampered by limited supply of vaccine. An alternative route of administration with reduced amounts of vaccine but without loss of vaccine efficacy would boost vaccination programmes.A randomized ...
Anna H Roukens +4 more
doaj +4 more sources
The Yellow Fever Vaccine Journey: Milestones and Future Directions [PDF]
Yellow fever, a mosquito-borne viral hemorrhagic disease, remains a significant public health concern in endemic regions of Africa and South America. The development of the yellow fever vaccine marked a milestone in virology and immunization.
Shriyansh Srivastava +13 more
doaj +2 more sources
Safe administration of yellow fever vaccine in patients with suspected egg allergy [PDF]
Background: The evidence available in the literature on the administration and safety of the yellow fever vaccine in patients with egg allergy is limited.
Fernanda Tormin Tanos Lopes, MSc +4 more
doaj +2 more sources
Yellow fever vaccine coverage and associated factors among under-five children in Kenya: Data from Kenyan Demographic and Health Survey 2022 [PDF]
Yellow fever is a vaccine preventable hemorrhagic disease that leads to morbidity and mortality in the affected individuals. The only options for preventing and controlling its spread are through vaccination.
Mohammed Seid Ali, Enyew Getaneh Mekonen
doaj +2 more sources
Estimating the number of unvaccinated Chinese workers against yellow fever in Angola [PDF]
Background A yellow fever epidemic occurred in Angola in 2016 with 884 laboratory confirmed cases and 373 deaths. Eleven unvaccinated Chinese nationals working in Angola were also infected and imported the disease to China, thereby presenting the first ...
A. Wilder-Smith, E. Massad
doaj +4 more sources
Case Report: Yellow Fever Vaccine-Associated Neurotropic Disease and Associated MRI, EEG, and CSF Findings [PDF]
Yellow fever vaccine-associated neurotropic disease (YEL-AND) is a rare and serious complication following vaccination with the 17D live attenuated yellow fever vaccine.
Michelle Cohen +12 more
doaj +2 more sources
Transmission of yellow fever vaccine virus from breast feeding mothers to their infants: reporting of yellow fever virus (YFV) RNA detection in milk specimens [version 4; peer review: 1 approved, 2 approved with reservations] [PDF]
Background Because of yellow fever’s serious impact on health, vaccination is the principal strategy to control the disease. Administration of the yellow fever vaccine to breastfeeding women should be before they complete 9 months post-delivery, in order
Abdel Rahim M El Hussein +6 more
doaj +2 more sources
Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study [PDF]
Background Pneumococcal conjugate vaccines (PCVs) effectively prevent pneumococcal disease, but the global impact of pneumococcal vaccination is hampered by its cost.
Grant A. Mackenzie +10 more
doaj +2 more sources
Yellow fever (YF) is an acute viral communicable disease transmitted by an arbovirus of the Flavivirus genus. It is primarily a zoonotic disease, especially the monkeys. Worldwide, an estimated 200,000 cases of yellow fever occurred each year, and the case-fatality rate is ~15%.
J. Erin Staples +3 more
+6 more sources
Yellow fever vaccination before and during the covid-19 pandemic in Brazil
OBJECTIVE To analyze the number of yellow fever vaccine doses administered before and during the covid-19 pandemic in Brazil. METHODS This is an ecological, time series study based on data from the National Immunization Program.
Tércia Moreira Ribeiro da Silva +6 more
doaj +1 more source

